Navigation Links


Sartorius at Biology News

Sartorius at Biology Products

VoluPAC Tubes from Sartorius AG

Description:The VoluPAC tubes provide a fast, easy to use, reproducible and reliable alternative to manual cell counting. They are 15 times faster and 5 times more accurate (margin of error less than 5%). The VoluPAC tubes enable the determination of the packed cell volume (PCV) in a cell suspension, resulting in absolute data correlating with parameters like protein content, cell count, metabolic activi...
Company:Sartorius AG

CERTOMAT RM from Sartorius AG

Description:The CERTOMAT RM is specifically designed as a high tech shaker for increased cell densities. The new variable mass compensation allows high shaking speed even under full load conditions yielding better aeration and, therefore, faster growth and higher cell density. This benchtop, orbital shaker is ideal when high reproducibility is critical Variable mass compensation allows high speed wit...
Company:Sartorius AG

CERTOMAT IS from Sartorius AG

Description:The CERTOMAT IS, a true benchtop incubator-shaker, has the smallest footprint of all our environmental shakers. Analogue out and interface RS232 </L...
Company:Sartorius AG

Vivaclear Centrifugal Filters from Sartorius AG

Description:Vivaclear centrifugal filters are disposable microfiltration devices for the fast and reliable clarification/filtration of biological samples in the range 100 l to 500 l. They can be used in fixed angle rotors accepting 2.2 ml centrifuge tubes. Fast and reproducible perf...
Company:Sartorius AG

Vivaspin 2 (10,000 MWCO Hydrosart) from Sartorius AG

Description:The new Vivaspin 2 bridges the gap between the 500 l and 4 ml centrifugal concentrators. This device combines the speed of the classic Vivaspin products with low internal surface and membrane area for superior recoveries from very dilute solutions. Available with a choice of PES, Cellulose Triacetate membranes, Vivaspin 2 offers the highest flexibility for process optimisation. Also un...
Company:Sartorius AG

More>>

Sartorius at Biology Technology
Sartorius at Medicine News
Sartorius at Medicine Products
Sartorius at Medicine Technology
Other Tagsturnedluckycracksdressdressdressdressinformedantitumor
(Date:7/25/2008)... The Retina Group of New York will present a...r degeneration especially designed for seniors. Th...ibrary at 116 Merritts Road, Farmingdale, NY 11735...ce is free and refreshments will be provided. The ...0. , Hicksville and Haupp...
(Date:7/25/2008)... The Drug Information Association (DIA) and ...he Critical Path Initiative (CPI) on the Move: Com...da, MD) and the Critical Path Transporter Workshop... Horsham, PA (PRWEB) July 25, 2005-- T...ociation (DIA)] and the Food and Drug Administrati...
(Date:7/25/2008)... Columbus-based law firm represents Pickerin...urchased at Columbus-area Kroger store , ...25, 2008 -- http://www.donaheyohioinjurylawyers.c...sonal injury law firms in central Ohio, has filed ...rt (Case No. 08CV9804) against The Kroger Co., in ...
(Date:7/24/2008)... Hoag to lease hospital facility on Sand Can...h, CA (Vocus) July 24, 2008 -- Hoag Memorial Hospi..., Inc. (NYSE: HCP), a Real Estate Investment Trust...-bed hospital facility on Sand Canyon Avenue near ...lity is currently operated by Tenet Healthcare Cor...
Breaking Medicine News(10 mins):Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2
(Date:7/25/2008)...he need to translate basic science discoveries in...w study by researchers at the Medical College of W... Health (NIH) identified reasons why clinical sci... reviews than basic science grant applications to ...ssue of The American Journal of Medicine . , In...
(Date:7/25/2008)...uly 25, 2008) New research published in the July ...urgeons shows elevated plasma DNA is a reliable m...so suggests that plasma DNA levels rise before cli...y of patients. , Esophageal cancer, one of the...lly diagnosed at a late stage. An accurate marker ...
(Date:7/24/2008)...stitutional team led by Massachusetts General Hosp...new tool for genomic research and medicine a robu...n target particular DNA sequences for inactivation...ell, the researchers describe an efficient, publi...inger nucleases (ZFNs), which can be used to induc...
(Date:7/24/2008)...bedded with a telescope promise to make it easier ...her activities requiring sharper distance vision. ...e the advantages of these innovative glasses over .../June issue of Journal of Biomedical Optics , mai... "This new design has several advantages," says th...
Breaking Biology News(10 mins):New study spotlights National Institutes of Health grant outcomes for clinical research 2Plasma DNA level is a reliable marker of recurrent esophageal cancer, study finds 2Consortium develops new method enabling routine targeted gene modification 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3SCAI announces 2009 annual scientific sessions in Las Vegas 19545 1SCAI announces 2009 annual scientific sessions in Las Vegas 19545 2WorldHeart Announces Possible Delisting Action by NASDAQ 19543 1WorldHeart Announces Possible Delisting Action by NASDAQ 19543 2WorldHeart Announces Possible Delisting Action by NASDAQ 19543 3Pharmasset Reports Financial Results for Quarter Ended March 31 2008 19541 1Pharmasset Reports Financial Results for Quarter Ended March 31 2008 19541 2Pharmasset Reports Financial Results for Quarter Ended March 31 2008 19541 3Pharmasset Reports Financial Results for Quarter Ended March 31 2008 19541 4Pharmasset Reports Financial Results for Quarter Ended March 31 2008 19541 5Pharmasset Reports Financial Results for Quarter Ended March 31 2008 19541 6Pharmasset Reports Financial Results for Quarter Ended March 31 2008 19541 7Pharmasset Reports Financial Results for Quarter Ended March 31 2008 19541 8APHA Applauds Congressional Passage of Farm Bill Urges President Not to Veto 19539 1
Other Contentsanorexiaanorexiaanorexiaanosmiacruciatecruciatecruciateantibioticsantibioticsantibioticsantibioticsantibioticsantibioticsantibioticsantifreezeantifreezeantifreezeantihypertensivesantidoteantidoteantidoteantidote